A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Acute Pulmonary Embolism

1997783 citationsJournal Articlebronze Open Access

Authors

Gérald Simonneau · Hôpital Antoine-Béclère

Hervé Sors · Hôpital Laennec

B Charbonnier · Centre Hospitalier Universitaire de Tours

Yves Page · Bellevue Hospital Center

Jean-Pierre Laaban

R. Azarian · Hôpital André Mignot

Marcel Laurent · Hotel Dieu Hospital

Abstract

Under the conditions of this study, initial subcutaneous therapy with the low-molecular-weight heparin tinzaparin appeared to be as effective and safe as intravenous unfractionated heparin in patients with acute pulmonary embolism.

Topics & Keywords

Venous Thromboembolism Diagnosis and Management Atrial Fibrillation Management and Outcomes Heparin-Induced Thrombocytopenia and Thrombosis

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 337, Issue 10, pp. 663-669

DOI: 10.1056/nejm199709043371002

Field-Weighted Citation Impact: 43.89